Literature DB >> 27261830

Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.

Lasse Skibsbye1, Ursula Ravens2.   

Abstract

Any disturbance of electrical impulse formation in the heart and of impulse conduction or action potential (AP) repolarization can lead to rhythm disorders. Potassium (K(+)) channels play a prominent role in the AP repolarization process. In this review we describe the causes and mechanisms of proarrhythmic effects that arise as a response to blockers of cardiac K(+) channels. The largest and chemically most diverse groups of compound targets are Kv11.1 (hERG) and Kv7.1 (KvLQT1) channels. Finally, the proarrhythmic propensity of atrial-selective K(+) blockers inhibiting Kv1.5, Kir3.1/3.4, SK, and K2P channels is discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiarrhythmic drugs; Cardiac action potentials; K(+) channels blockers; Mechanism of arrhythmia; Proarrhythmic effects

Mesh:

Substances:

Year:  2016        PMID: 27261830     DOI: 10.1016/j.ccep.2016.02.004

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  2 in total

1.  Effect of selective IK,ACh inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation.

Authors:  Merle Friederike Fenner; Helena Carstensen; Sarah Dalgas Nissen; Eva Melis Hesselkilde; Christine Scott Lunddahl; Maja Adler Hess Jensen; Ameli Victoria Loft-Andersen; Stefan Michael Sattler; Pyotr Platonov; Said El-Haou; Claire Jackson; Raymond Tang; Robert Kirby; John Ford; Ulrich Schotten; James Milnes; Ulrik Svane Sørensen; Thomas Jespersen; Rikke Buhl
Journal:  Br J Pharmacol       Date:  2020-06-24       Impact factor: 8.739

2.  Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.

Authors:  Austin B Schwartz; Anshika Kapur; Wentao Wang; Zhenbo Huang; Erminia Fardone; Goutam Palui; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.